+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Polycystic Ovary Syndrome"

From
From
From
From
From
Market Spotlight: Polycystic Ovary Syndrome (PCOS) (2020) - Product Thumbnail Image

Market Spotlight: Polycystic Ovary Syndrome (PCOS) (2020)

  • Report
  • March 2020
  • 29 Pages
  • Global
Polycystic Ovarian Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Polycystic Ovarian Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 55 Pages
  • Global
From
Women Infertility - Pipeline Review, H2 2020 - Product Thumbnail Image

Women Infertility - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 232 Pages
  • Global
From
From
From
Loading Indicator

Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. It is characterized by a hormonal imbalance, which can lead to irregular menstrual cycles, infertility, and other physical and psychological symptoms. PCOS is also associated with an increased risk of developing type 2 diabetes, cardiovascular disease, and endometrial cancer. PCOS is a major public health concern, as it affects an estimated 5-10% of women of reproductive age worldwide. Diagnosis and management of PCOS can be challenging due to its complex and varied symptoms. Treatment typically involves lifestyle modifications, such as diet and exercise, as well as medications to regulate hormones and reduce symptoms. The PCOS market is a growing segment of the women's health industry, with a range of products and services available to diagnose and manage the condition. Companies in the PCOS market include pharmaceutical companies, medical device manufacturers, and digital health companies. Examples include AbbVie, Bayer, and Ovascience. Show Less Read more